Navigation Links
DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines
Date:6/30/2013

The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society (IAS) Conference, include new antiretroviral (ARV) therapy (ART) recommendations for HIV-infected children, and will mean that more children will be on better treatments. The Drugs for Neglected Diseases initiative (DNDi) applauds the new guidelines and, with Cipla Ltd. and other partners, is expediting the development of urgently needed 4-in-1 ARVs adapted for babies and toddlers with HIV, to be delivered by 2015.

The new 2013 WHO Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection were released today at the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention. The updated guidelines call for immediate ART for all HIV-infected children under five years of age, regardless of clinical or immunological status, which will greatly broaden the pediatric HIV patient population on treatment and thus increase demand. Importantly, the guidelines also recommend the use of potent protease inhibitor-based first-line ARV regimens, ideally in a fixed-dose combination (FDC), for all children under three years old.

'The new international guidelines call for getting many more young kids with HIV on the best treatment with no delay', said Dr Bernard Pcoul, Executive Director of DNDi. ''We are reassured that the pediatric ARV formulation we are striving to deliver to babies and toddlers with HIV is completely aligned with the WHO's new recommendations.'

Welcoming the new international HIV guidelines, Dr Jaideep A Gogtay, Chief Medical Officer of Cipla, said, 'Cipla reinforces its commitment towards HIV/AIDS and will continue to develop novel and child-friendly formulations to ensure wider access of ARV drugs to HIV-infected children.'

An estimated 3.3 million children (<15 years old) live with HIV/AIDS, but only 28% of those in need of treatment are receiving it, compar
'/>"/>

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. NYU Langone experts present research, clinical advances at neurosurgeons meeting
4. Experimental Gel May Help Those With Advanced Parkinsons
5. Triple negative breast cancer symposium highlights current advances
6. Advanced genetic screening method may speed vaccine development
7. Advanced Prostate Cancer Drug May Help at Earlier Stage
8. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
9. Studies See Advances in Detecting, Treating Pancreatic Cancer
10. GW researchers discover biomarker for advanced bile duct fibrosis and bile duct cancer
11. New England Journal of Medicine hails new skin cancer drug as greatest advance yet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... Step into a macabre world where ... of Virginia. Wicked Plants, the Museum’s latest featured exhibition, ... poisonous, carnivorous and diabolical plants inside of a dilapidated, ... the biochemical, physical and neurological processes between botanicals and ...
(Date:12/26/2014)... It is said that nothing makes a ... the famous wedding dress supplier, shows its new selection ... gown promotion. , UWDress.com’s navy cocktail gowns are the ... in high fashion styles. Simple dresses in bright neon colors ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... dose of lopinavir/ritonavir, study says , , ... with tazanavir/ritonavir (A/R) is as effective as twice-daily ... are starting antiretroviral treatment for the first time, ... findings, the researchers recommended once-daily A/R as a ...
... National Institute of Mental Health currently conducting a study regarding Cognitive Behavioral ... only place where unhealthy weight loss is developing into a crisis. ... Therapy, including OCD. Dr. Allison Conner provides thoughts on the study. ... ...
... Aug. 1 Kensey Nash Corporation,(Nasdaq: KNSY ) ... its fourth quarter and fiscal year ended June 30, ... 2008., Joe Kaufmann, President and CEO, will be ... 21, 2008 at 9:00 A.M.,Eastern Time., To participate ...
... one of the most aggressive types of brain tumor, ... therapeutics inhibiting a group of proteins known as receptor ... with GBM, these RTK inhibitors have met with limited ... respond to such treatment and most subsequently relapse after ...
... is a time of great excitement and anticipation. It ... women with type 1 or type 2 diabetes. Pregnancy ... But a new, easy-to-read booklet has information to help ... For Women with Diabetes: Your Guide to Pregnancy is ...
... Health Care to Focus on,Individual Responsibility and Rural Health, ... a landmark health care policy forum, titled, "Reforming the ... the Dole,Institute of Politics in Lawrence, Kansas. The event ... to 5:00 p.m. (CDT), in the Institute,s,Hansen Hall, 2350 ...
Cached Medicine News:Health News:Once-Daily Combo Works for New HIV Patients 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 3Health News:Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference 2Health News:Senator Bob Dole to Hold Landmark Health Care Forum at Dole Institute of Politics in Kansas 2Health News:Senator Bob Dole to Hold Landmark Health Care Forum at Dole Institute of Politics in Kansas 3
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  ViewRay™, a privately held medical device ... exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange ... for the treatment of cancer in Japan ... the world,s first and only MRI-guided radiation therapy system ...
(Date:1/22/2015)... 22, 2015  ResMed Inc. (NYSE: RMD ) today ... for the quarter was $423.0 million, a 10 percent increase ... percent increase on a constant currency basis). Net income was ... quarter ended December 31, 2013. Diluted earnings per share for ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
... intended for monitoring the accuracy and precision of ... in vitro diagnostic use only. Provided in a ... up to ten days stability at 2 ... used in accordance with the directions accompanying the ...
PowerMed is a billing software....
Managed care is a billing and tracking system....
Medicine Products: